Preventing neural tube defects in Europe: population based study.

Hdl Handle:
http://hdl.handle.net/10147/323826
Title:
Preventing neural tube defects in Europe: population based study.
Authors:
Busby, Araceli; Abramsky, Lenore; Dolk, Helen; Armstrong, Ben
Affiliation:
London School of Hygiene and Tropical Medicine, London WC1E 7HT. araceli.busby@lshtm.ac.uk
Citation:
Busby A et al. Preventing neural tube defects in Europe: population based study. 2005, 330 (7491):574-5 BMJ
Journal:
BMJ (Clinical research ed.)
Issue Date:
12-Mar-2005
URI:
http://hdl.handle.net/10147/323826
DOI:
10.1136/bmj.330.7491.574
PubMed ID:
15760997
Additional Links:
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC554030/
Item Type:
Article
Language:
en
Description:
Each year, more than 4500 pregnancies in the European Union are affected by neural tube defects. Unambiguous evidence of the effectiveness of periconceptional folic acid in preventing neural tube defects has been available since 1991,1 and improving folate status sufficiently could result in the prevention of more than two thirds of all neural tube defects. We report on trends in the prevalence of neural tube defects up to 2001, in the context of a survey in 16 European countries of periconceptional folic acid policies and their implementation
Keywords:
FOLIC ACID; POPULATION BASED AND PREVENTIVE SERVICES
Local subject classification:
NEURAL TUBE DEFECTS
MeSH:
Europe; Humans; Infant, Newborn; Neural Tube Defects; Prevalence; Registries
ISSN:
1756-1833

Full metadata record

DC FieldValue Language
dc.contributor.authorBusby, Aracelien_GB
dc.contributor.authorAbramsky, Lenoreen_GB
dc.contributor.authorDolk, Helenen_GB
dc.contributor.authorArmstrong, Benen_GB
dc.date.accessioned2014-07-25T14:07:34Z-
dc.date.available2014-07-25T14:07:34Z-
dc.date.issued2005-03-12-
dc.identifier.citationBusby A et al. Preventing neural tube defects in Europe: population based study. 2005, 330 (7491):574-5 BMJen_GB
dc.identifier.issn1756-1833-
dc.identifier.pmid15760997-
dc.identifier.doi10.1136/bmj.330.7491.574-
dc.identifier.urihttp://hdl.handle.net/10147/323826-
dc.descriptionEach year, more than 4500 pregnancies in the European Union are affected by neural tube defects. Unambiguous evidence of the effectiveness of periconceptional folic acid in preventing neural tube defects has been available since 1991,1 and improving folate status sufficiently could result in the prevention of more than two thirds of all neural tube defects. We report on trends in the prevalence of neural tube defects up to 2001, in the context of a survey in 16 European countries of periconceptional folic acid policies and their implementationen_GB
dc.language.isoenen
dc.relation.urlhttp://www.ncbi.nlm.nih.gov/pmc/articles/PMC554030/en_GB
dc.rightsArchived with thanks to BMJ (Clinical research ed.)en_GB
dc.subjectFOLIC ACIDen_GB
dc.subjectPOPULATION BASED AND PREVENTIVE SERVICESen_GB
dc.subject.meshEurope-
dc.subject.meshHumans-
dc.subject.meshInfant, Newborn-
dc.subject.meshNeural Tube Defects-
dc.subject.meshPrevalence-
dc.subject.meshRegistries-
dc.subject.otherNEURAL TUBE DEFECTSen_GB
dc.titlePreventing neural tube defects in Europe: population based study.en_GB
dc.typeArticleen
dc.contributor.departmentLondon School of Hygiene and Tropical Medicine, London WC1E 7HT. araceli.busby@lshtm.ac.uken_GB
dc.identifier.journalBMJ (Clinical research ed.)en_GB

Related articles on PubMed

All Items in Lenus, The Irish Health Repository are protected by copyright, with all rights reserved, unless otherwise indicated.